[Experimental study and preliminary clinical application of bacterial collagenase in catabolizing scars]

Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi. 1999 May;15(3):202-5.
[Article in Chinese]

Abstract

Objective: To investigate the mechanism of collagenase in degradation of hypertrophic scars and observe the clinical effects of this therapy.

Methods: Both animal experiment and clinical trial were conducted.

Results: The injection of collagenase into the hypertrophic scar tissues in nude mice resulted in 86% volume reduction after two injections within two weeks, while the control tissues reduced only by 35% during the same time. Clinically, 13 cases were treated with intralesional injection of bacterial collagenase. The volume reduction rate was 46.92% in average within two weeks. The volume reduction in 4 of 13 cases was above 50%. Three to sixteen months' follow-up of five patients revealed that only one case of keloid recurred after treatment in the second month. Examinations of histological sections and TEM showed the dissolved collagen fiber clearly.

Conclusion: Collagenase can degrade collagen fiber directly. The prompt significant effects and the mild complications make it a prospective therapy.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Animals
  • Child
  • Cicatrix, Hypertrophic / drug therapy*
  • Cicatrix, Hypertrophic / pathology
  • Female
  • Humans
  • Injections, Intralesional
  • Keloid / drug therapy*
  • Keloid / pathology
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Microbial Collagenase / administration & dosage
  • Microbial Collagenase / therapeutic use*

Substances

  • Microbial Collagenase